Through the eye of the Covid storm
‘What doesn’t kill you makes you stronger’. Ditto for radiation detection expert Kromek, which was...
Read moreFurther progress & strong cash generation
Quality firms often use a crisis as a catalyst to streamline operations and improve services: not...
Read moreProving the doubters wrong
Northbridge’s results for 6 months to June were most encouraging, with revenues falling just 4.5%...
Read more
Upgrades after results and strategic deal
Strix has published reassuring interims and announced the acquisition of LAICA, conditional upon...
Read more
One of most compelling stocks on AIM
The €8bn BuildTech sector is at the heart of the digital transformation of the vast global...
Read moreIn the right place at the right time
We think this ‘battle-hardened’, cash-rich (estimated April '21 net funds of £6.1m) & now...
Read morePlenty of progress in H1
Having navigated the challenge of running a clinical trial during a global pandemic, Destiny has...
Read moreInterim results: resilience and confidence
Overall performance shows resilience to the impact of COVID-19, with comprehensive restructuring...
Read moreEMA safety nod for game-changer BMK08
Benchmark has received a notification of positive safety opinion from the European Medicines Agency...
Read more
Register to be first
Get research on the companies that interest you straight to your inbox
